Article Details

US clears AstraZeneca buyout of Alexion amid closer scrutiny of biopharma M&A

Retrieved on: 2021-04-16 15:56:15

Tags for this article:

Click the tags to see associated articles and topics

US clears AstraZeneca buyout of Alexion amid closer scrutiny of biopharma M&A. View article details on hiswai:

Excerpt

Three deals in 2019 — Roche's buyout of Spark Therapeutics, Bristol Myers Squibb's purchase of Celgene, and AbbVie's acquisition of Allergan ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo